BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 1575168)

  • 1. Circulatory and extracirculatory effects of angiotensin-converting enzyme inhibition.
    Weber MA; Neutel JM; Smith DH
    Am Heart J; 1992 May; 123(5):1414-20. PubMed ID: 1575168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of angiotensin-converting enzyme inhibitors on tissue renin-angiotensin systems.
    Lee MA; Paul M; Böhm M; Ganten D
    Am J Cardiol; 1992 Oct; 70(10):12C-19C. PubMed ID: 1414888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of tissue renin-angiotensin systems in hypertension and effects of chronic converting-enzyme inhibition.
    Keuneke C; Yacullo R; Metzger R; Hellmann T; Peters J; Ganten D
    Eur Heart J; 1990 May; 11 Suppl D():11-6. PubMed ID: 2163328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What we would like to know about the antihypertensive mechanisms of angiotensin converting enzyme inhibition.
    Brunner HR; Waeber B; Nussberger J
    J Hypertens Suppl; 1988 Dec; 6(3):S1-5. PubMed ID: 3066876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin converting enzyme inhibitors and moderate hypertension.
    McAreavey D; Robertson JI
    Drugs; 1990 Sep; 40(3):326-45. PubMed ID: 2226219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of enalapril maleate on blood pressure, renin-angiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension.
    Cerasola G; Cottone S; D'Ignoto G; Grasso L; Carone MB; Carapelle E; Contorno A
    Clin Ther; 1987; 9(4):390-9. PubMed ID: 3038326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin converting enzyme inhibition: discrepancy between antihypertensive effect and suppression of enzyme activity.
    Waeber B; Nussberger J; Juillerat L; Brunner HR
    J Cardiovasc Pharmacol; 1989; 14 Suppl 4():S53-9. PubMed ID: 2483430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From tissue angiotensin converting enzyme inhibition to antihypertensive effect.
    Veltmar A; Gohlke P; Unger T
    Am J Hypertens; 1991 Mar; 4(3 Pt 2):263S-269S. PubMed ID: 2043316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-converting enzyme inhibition with quinapril (CI-906) and captopril in spontaneously hypertensive rats with suppressed renin-angiotensin system.
    Säynävälammi P; Pörsti I
    Methods Find Exp Clin Pharmacol; 1987 Jun; 9(6):325-31. PubMed ID: 3309510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin-converting enzyme in cardiovascular and adrenal tissues and implications for successful blood pressure management.
    Melby JC
    Am J Cardiol; 1992 Apr; 69(10):2C-7C. PubMed ID: 1546636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.
    Linz W; Wiemer G; Gohlke P; Unger T; Schölkens BA
    Pharmacol Rev; 1995 Mar; 47(1):25-49. PubMed ID: 7784479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme inhibitors: mechanistic controversies.
    Ujhelyi MR; Ferguson RK; Vlasses PH
    Pharmacotherapy; 1989; 9(6):351-62. PubMed ID: 2559394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of an angiotensin-converting-enzyme inhibitor on the plasma concentration of cytokines and vasoactive molecules in patients with coronary heart disease and hypertension].
    Khadartsev AA; Logatkina AV; Terekhov IV; Bondar SS; Bondar NV
    Ter Arkh; 2017; 89(12):97-102. PubMed ID: 29411767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renin inhibitors, angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists: relationships between blood pressure responses and effects on the renin-angiotensin system.
    Schalekamp MA; Derkx FH; van den Meiracker AH
    J Hypertens Suppl; 1992 Dec; 10(7):S157-64. PubMed ID: 1291650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinin-related effects of angiotensin-converting enzyme inhibition.
    Bönner G
    Clin Physiol Biochem; 1990; 8 Suppl 1():6-15. PubMed ID: 2257722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurohormonal reactivation in heart failure patients on chronic ACE inhibitor therapy: a longitudinal study.
    Lee AF; MacFadyen RJ; Struthers AD
    Eur J Heart Fail; 1999 Dec; 1(4):401-6. PubMed ID: 10937954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system.
    Scheen AJ
    Drugs; 2004; 64(22):2537-65. PubMed ID: 15516153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme inhibitors in hypertension: a review.
    Salvetti A; Pedrinelli R; Arzilli F; Abdel-Haq B; Magagna A; Lucarini A; Graziadei L; Nuccorini A; Taddei S
    Int J Clin Pharmacol Res; 1985; 5(6):429-38. PubMed ID: 3005182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology of angiotensin-converting enzyme inhibitors as a guide to their use in congestive heart failure.
    Cody RJ
    Am J Cardiol; 1990 Oct; 66(11):7D-11D; discussion 11D-13D. PubMed ID: 2220605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.